Come up with a name for your new list and we'll add to it:
Sinopia Biosciences raised a round of funding on September 13, 2016. Investors include
National Institute of General Medical Sciences.
Sinopia is a computational biology company focusing on identifying and repurposing drugs to prevent or lower the serious side effects of major therapeutics. The company uses its proprietary machine le…